Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Highlights NV-387 as Potential Measles Treatment
Via Investor Brand Network
Tickers NNVC
Exposures COVID-19 Product Safety
News headline image
Federal Court Reportedly Halts Kennedy's Vaccine Panel, Putting COVID, Flu And RSV Shots At Risk ↗
Via Benzinga
Exposures COVID-19 Product Safety
News headline image
Therapeutics Q4 Earnings: Novavax (NASDAQ:NVAX) Simply the Best
Via StockStory
Topics Artificial Intelligence
Tickers BIIB NVAX
Exposures Artificial Intelligence COVID-19
News headline image
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
Via StockStory
Topics Artificial Intelligence
Tickers NTRA NVAX
Exposures Artificial Intelligence COVID-19
News headline image
Warsh's Fed Confirmation Hearing Starts Tomorrow. 3 Huge Things Investors Should Listen For ↗
Via The Motley Fool
Topics Bonds Economy Government
Exposures COVID-19 Debt Markets Economy
News headline image
The Stock Market's Fear & Greed Index Just Shifted Toward Greed. History Says This Is What Happens Next for S&P 500 Investors. ↗
Via The Motley Fool
Topics Bonds Stocks
Exposures COVID-19 Debt Markets US Equities
BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial Highlighting Biotech’s Shift Toward Science-Driven Asset Valuation
Via Investor Brand Network
Topics Artificial Intelligence
Tickers ALNY ARCT DNLI OTLC SRPT
Exposures Artificial Intelligence COVID-19
News headline image
ICON (ICLR) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers ICLR
Exposures COVID-19 Financial
News headline image
ICON (ICLR) Q1 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Artificial Intelligence Earnings
Tickers ICLR
Exposures Artificial Intelligence COVID-19 Financial
News headline image
Adaptive Biotechnologies' COO Is Running a Systematic Sell Program — Here's What It Means ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers ADPT
Exposures COVID-19 Legal Regulatory
News headline image
Moderna's Quarterly Earnings Preview: What You Need to Know
Via Barchart.com
Topics ETFs Intellectual Property
Exposures COVID-19 Intellectual Property
News headline image
The Market Is Nervous. This Growth Stock Is Your Shot at Doubling Up. ↗
Via The Motley Fool
Topics Economy
Tickers CHWY
Exposures COVID-19 Economy Interest Rates
News headline image
The TSX Stocks I’d Use to Anchor a More Defensive 2026 Portfolio ↗
Via The Motley Fool
Tickers TSX:L TSX:WCN
Exposures COVID-19
News headline image
Will There Ever Be Another Dogecoin or Shiba Inu? ↗
Via The Motley Fool
Exposures COVID-19
News headline image
Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares? ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers ADPT
Exposures COVID-19 Legal Regulatory
News headline image
The Nasdaq Just Did Something It Hasn't Done Since 2020, and Here's What Could Happen Next ↗
Via The Motley Fool
Topics Artificial Intelligence Economy
Tickers AMD AMZN AVGO GOOG GOOGL META
Exposures Artificial Intelligence COVID-19 Economy
News headline image
The Last Time Microsoft Stock Was This Cheap Was 2017 ↗
Via The Motley Fool
Topics Artificial Intelligence
Tickers MSFT
Exposures Artificial Intelligence COVID-19
News headline image
Lucent Psych Expands Telepsychiatry Services in Washington and Texas
Via TheNewswire.com
Exposures COVID-19
News headline image
The Forex Trading Coach Confirm The Launch Of Their New Website
Via Press Release Distribution Service
Topics Brexit Economy
Exposures Brexit COVID-19 Interest Rates
News headline image
Telehealth Drives Surge in Medical Cannabis Evaluations, Industry Data Shows
Via BusinesNews Wire
Topics Cannabis
Exposures COVID-19 Cannabis
News headline image
Investors Are Walking on Eggshells These Days. Yet the S&P 500 Index Is on the Cusp of Doing Something Extraordinary for Only the 4th Time in 20 Years. ↗
Via The Motley Fool
Topics Economy Stocks
Tickers DB
Exposures COVID-19 Economy Interest Rates
BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Reports FY 2025 Net Income of $249 Million
Via Investor Brand Network
Topics Artificial Intelligence
Tickers OTLC
Exposures Artificial Intelligence COVID-19
News headline image
Illinois Tool Works in 5 Years: Boom, Bust, or Quietly Crushing It? ↗
Via The Motley Fool
Tickers ITW
Exposures COVID-19
News headline image
3 Absurdly Cheap Stocks to Buy With $1,000 While the Market Is This Nervous ↗
Via The Motley Fool
Tickers AAPL CLX DPZ TGT
Exposures COVID-19
News headline image
Pennsylvania Central District Knights of Columbus Gather in Scranton to Celebrate Growth, Honor Master Brian Hallock and staff at the Final Biennial Meeting for the 2022-2026 District Leadership
Via 24-7 Press Release
Tickers U
Exposures COVID-19
News headline image
ApiquestUSA Secures Landmark U.S. Patent, Propelling Apivirine to the Forefront of Natural Antiviral Innovation"
Via 24-7 Press Release
Topics Intellectual Property
Exposures COVID-19 Intellectual Property Product Safety
News headline image
3 Reasons Investors Love Magnite (MGNI)
Via StockStory
Tickers MGNI
Exposures COVID-19
News headline image
Online Retail Stocks Q4 Highlights: Wayfair (NYSE:W)
Via StockStory
Tickers W
Exposures COVID-19
News headline image
2 Healthcare Stocks to Buy and 1 to Approach With Caution ↗
Via The Motley Fool
Tickers BMY BNTX NTLA ZTS
Exposures COVID-19
News headline image
TRAWS PHARMA INC (NASDAQ:TRAW) Reports 2025 Earnings Beat Amid Dilutive $60M PIPE Financing and FDA Hold ↗
Via Chartmill
Topics Earnings
Tickers TRAW
Exposures COVID-19 Financial Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.